Bristol-Myers Squibb Co <BMY.N>: Truist Securities raises target price to $70 from $65
BMY•Related News
Oppenheimer 2Q FY26 net income rises 26.2% to $27.35 million; revenue increases 21.9% to $454.88 million
OPY•
Global markets-Stocks climb as strong tech results reignite AI trade, yen swings
QQQ•
Abercrombie & Fitch schedules quarterly earnings call for second-quarter results
ANF•
Elutia to report Q2 2026 results after market close, host conference call
ELUT•
Wearable Devices issues 1,000,000 warrants with $3.16 exercise price in $3.3 million private placement
WLDS•